Information on Acomplia� (Rimonabant) (Possibly Zimulti�)

Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia� and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. This diet pill was officially approved in Britain on June 28th 2006. It has also be approved in several other European countries and other countries around the world. Which could someday lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market. And it recently did not approve it for the USA.

Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication (as any) obviously does not come without some potential side effects for its user but could offer more that others. Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug. Studies also show that it increases levels of HDL (good cholesterol) while at the same time reducing the triglycerides (bad cholesterol). It could also possibly be used as a smoking cessation although not officially approved as one (yet).

rimonabant acomplia

�2007

Daily Diet Tips The Daily Diet Tips are only generalized tips we do not necessarily endorse them nor are we responsible for their effectiveness.

Please Note the FDA has Not approved Rimonabant (Acomplia� Zimulti�) for use in the USA.
If you are from the USA proceed here. Be sure to read the disclaimer and follow all local laws regarding this medication. If you wish to inquire about this medication, see the following.

Buy Acomplia Rimonabant Zimulti in USA And Europe Online.

Acomplia Rimonabant (Zimulti), the new age diet pill is developed by world’s third largest French pharmaceutical Sanofi-Aventis, to help ever growing number of obese popula tion across the world.

This drug Rimonabant Acomplia works differently to most other weight loss drugs available in market.

Acomplia (Rimonabant) works in an entirely different way, by blocking CB1 a “pleasure center” in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Sanofi Clinical research shows that Acomplia Rimonabant (Zimulti) also might help people quit smoking as well. Rimonabant clinical trial has proved its effectiveness in loosing weight as compared to other weight loss drugs. Rimonabant Acomplia treatment should be accompanied with a low calorie diet and an exercise plan to obtain considerable amount of weight loss. Buy Rimonabant Acomplia treatment online for a steady weight loss race.

Sanofi-Synthelabo, a French Pharmaceutical Company created Rimonabant (Acomplia� and possibly Zimulti) which is a new drug treatment for obesity and possibly other ailments. This diet pill was officially approved in Britain on June 28th 2006. It has also be approved in several other European countries and other countries around the world. Which could someday lead the way to having the FDA approve it for the United States. But no guarantees, The FDA has strick policies regarding new medications on the market. And it recently did not approve it for the USA.

Acomplia (Rimonabant or Zimulti) diet pills offer hope for obese individuals. Especially where other treatments had little affect or whose side effects where too much to handle. This medication (as any) obviously does not come without some potential side effects for its user but could offer more that others. Rimonabant works differently than other weightloss pills, and has other potential benefits than any other diet drug. Studies also show that it increases levels of HDL (good cholesterol) while at the same time  reducing the triglycerides (bad cholesterol). It could also possibly be used as a smoking cessation although not officially approved as one (yet).